Cargando…
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
Pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus 19 disease (COVID-19) which presents a large spectrum of manifestations with fatal outcomes in vulnerable people over 70-years-old and with hypertension, diabetes, obesity, cardiovascular disease, COPD, and smok...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652413/ https://www.ncbi.nlm.nih.gov/pubmed/33164751 http://dx.doi.org/10.7554/eLife.61390 |
_version_ | 1783607705982730240 |
---|---|
author | Zamorano Cuervo, Natalia Grandvaux, Nathalie |
author_facet | Zamorano Cuervo, Natalia Grandvaux, Nathalie |
author_sort | Zamorano Cuervo, Natalia |
collection | PubMed |
description | Pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus 19 disease (COVID-19) which presents a large spectrum of manifestations with fatal outcomes in vulnerable people over 70-years-old and with hypertension, diabetes, obesity, cardiovascular disease, COPD, and smoking status. Knowledge of the entry receptor is key to understand SARS-CoV-2 tropism, transmission and pathogenesis. Early evidence pointed to angiotensin-converting enzyme 2 (ACE2) as SARS-CoV-2 entry receptor. Here, we provide a critical summary of the current knowledge highlighting the limitations and remaining gaps that need to be addressed to fully characterize ACE2 function in SARS-CoV-2 infection and associated pathogenesis. We also discuss ACE2 expression and potential role in the context of comorbidities associated with poor COVID-19 outcomes. Finally, we discuss the potential co-receptors/attachment factors such as neuropilins, heparan sulfate and sialic acids and the putative alternative receptors, such as CD147 and GRP78. |
format | Online Article Text |
id | pubmed-7652413 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-76524132020-11-12 ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities Zamorano Cuervo, Natalia Grandvaux, Nathalie eLife Cell Biology Pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus 19 disease (COVID-19) which presents a large spectrum of manifestations with fatal outcomes in vulnerable people over 70-years-old and with hypertension, diabetes, obesity, cardiovascular disease, COPD, and smoking status. Knowledge of the entry receptor is key to understand SARS-CoV-2 tropism, transmission and pathogenesis. Early evidence pointed to angiotensin-converting enzyme 2 (ACE2) as SARS-CoV-2 entry receptor. Here, we provide a critical summary of the current knowledge highlighting the limitations and remaining gaps that need to be addressed to fully characterize ACE2 function in SARS-CoV-2 infection and associated pathogenesis. We also discuss ACE2 expression and potential role in the context of comorbidities associated with poor COVID-19 outcomes. Finally, we discuss the potential co-receptors/attachment factors such as neuropilins, heparan sulfate and sialic acids and the putative alternative receptors, such as CD147 and GRP78. eLife Sciences Publications, Ltd 2020-11-09 /pmc/articles/PMC7652413/ /pubmed/33164751 http://dx.doi.org/10.7554/eLife.61390 Text en © 2020, Zamorano Cuervo and Grandvaux http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Cell Biology Zamorano Cuervo, Natalia Grandvaux, Nathalie ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities |
title | ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities |
title_full | ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities |
title_fullStr | ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities |
title_full_unstemmed | ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities |
title_short | ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities |
title_sort | ace2: evidence of role as entry receptor for sars-cov-2 and implications in comorbidities |
topic | Cell Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652413/ https://www.ncbi.nlm.nih.gov/pubmed/33164751 http://dx.doi.org/10.7554/eLife.61390 |
work_keys_str_mv | AT zamoranocuervonatalia ace2evidenceofroleasentryreceptorforsarscov2andimplicationsincomorbidities AT grandvauxnathalie ace2evidenceofroleasentryreceptorforsarscov2andimplicationsincomorbidities |